ACR24 - JAK_TYK2
Rheumnow Podcast
00:00
Managing RA Patients During COVID-19 Vaccinations
This chapter reviews key research findings on the management of rheumatoid arthritis patients during COVID-19 vaccinations, particularly regarding the use of JAK inhibitors and IL-17 agents. It discusses the implications of holding biologics during vaccination, the efficacy of different treatments, and provides insights into the safety of JAK treatments, with a focus on emerging therapies and their impact on immune response.
Transcript
Play full episode
